Hjem › Type 2-diabetes › Nevada
Type 2-diabetes kliniske forsøg i Nevada
18 studier for Type 2-diabetes søger deltagere på steder i Nevada.
Byer i Nevada
Officiel studietekst (engelsk)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Excel Clinical Research, LLC, Las Vegas
- Palm Research Center Tenaya, Las Vegas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Palm Research Center Inc-Vegas, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Las Vegas Clinical Trials, Las Vegas
- AB Clinical Trials, Las Vegas
- Palm Research Center, Las Vegas
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Palm Research Center, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Southwest Medical Associates- Optum Nevada, Las Vegas
- Vector Clinical Trials, Las Vegas
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07776509A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- DaVita Clinical Research, Las Vegas
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 11. sep. 2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Henderson
- Research Site, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Alliance Clinical - Las Vegas, Las Vegas
- Palm Research Center, Inc., Las Vegas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07296484A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Vector Clinical Trials, Las Vegas
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT07215559Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Palm Research Center Inc, Las Vegas
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Palm Research Center Inc-Vegas, Las Vegas
RekruttererFase 3
Alder 45 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662044Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Santa Rosa Medical Centers of Nevada, Las Vegas
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT07527650Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Excel Clinical Research, Las Vegas
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 15. jun. 2026 · NCT07502508HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Alliance Clinical Las Vegas (Excel Clinical Research), Las Vegas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. apr. 2026 · NCT07546929Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.